(Q37194772)

18 August 2017

1 reference

title

Dengue vaccines for travelers (English)

1 reference

18 August 2017

0 references

Annelies Wilder-Smith

series ordinal

1

object named as

Annelies Wilder-Smith

0 references

author name string

Jacqueline L Deen

series ordinal

2

1 reference

18 August 2017

publication date

1 July 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

569-578

1 reference

The global emergence/resurgence of arboviral diseases as public health problems

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Illness in Journalists and Relief Workers Involved in International Humanitarian Assistance Efforts in Somalia, 1992-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Dengue Seroconversion among Israeli Travelers to Tropical Countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Epidemiology and prevention of hepatitis A in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Travel-acquired dengue infection: clinical spectrum and diagnostic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Fever in returned travelers: review of hospital admissions for a 3-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Epidemiology of travel-related hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

GeoSentinel: the global emerging infections sentinel network of the International Society of Travel Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Spectrum of disease and relation to place of exposure among ill returned travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Dengue fever among travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Post-infectious fatigue syndrome in dengue infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Prospects for a dengue virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Fulminant hepatitis in dengue haemorrhagic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Acute transverse myelitis following dengue virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Neurological manifestations of dengue infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Severe dengue virus infection in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Severe dengue virus infection in travelers: risk factors and laboratory indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Epidemiologic studies on Dengue in Santiago de Cuba, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Dengue and yellow fever--challenges for the development and use of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

The future of dengue vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

New developments in flavivirus vaccines with special attention to yellow fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Live flavivirus vaccines: reasons for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Live attenuated tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Development of a live attenuated dengue virus vaccine using reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Vaccines against dengue: a review of current candidate vaccines at advanced development stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Recombination and flavivirus vaccines: a commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Editorial: the challenge of dengue vaccine development and introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.569

21 January 2018

Identifiers

DOI

10.1586/14760584.7.5.569

1 reference

18 August 2017

1 reference